Ding, P.Q.; Tam, V.C.; Ramjeesingh, R.; Asselah, J.; Sheffield, B.S.; Mitchell, T.; Gaudreau, A.-J.; Knox, J.J.; Cheung, W.Y.
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program. Curr. Oncol. 2025, 32, 405.
https://doi.org/10.3390/curroncol32070405
AMA Style
Ding PQ, Tam VC, Ramjeesingh R, Asselah J, Sheffield BS, Mitchell T, Gaudreau A-J, Knox JJ, Cheung WY.
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program. Current Oncology. 2025; 32(7):405.
https://doi.org/10.3390/curroncol32070405
Chicago/Turabian Style
Ding, Philip Q., Vincent C. Tam, Ravi Ramjeesingh, Jamil Asselah, Brandon S. Sheffield, Taylor Mitchell, Anne-Julie Gaudreau, Jennifer J. Knox, and Winson Y. Cheung.
2025. "Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program" Current Oncology 32, no. 7: 405.
https://doi.org/10.3390/curroncol32070405
APA Style
Ding, P. Q., Tam, V. C., Ramjeesingh, R., Asselah, J., Sheffield, B. S., Mitchell, T., Gaudreau, A.-J., Knox, J. J., & Cheung, W. Y.
(2025). Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program. Current Oncology, 32(7), 405.
https://doi.org/10.3390/curroncol32070405
